|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA
* To whom correspondence should be addressed. E-mail: mdsansg{at}umich.edu.
Cholecystokinin (CCK) increases the rate of net protein synthesis in rat pancreatic acini by activating initiation and elongation factors required for translation. The immunosupressant FK506 inhibits the Ca2+/calmodulin-dependent phosphatase calcineurin in pancreatic acinar cells and blocks pancreatic growth induced by chronic CCK treatment. To test a requirement for calcineurin in the activation of the translational machinery stimulated by CCK we evaluated the effects of FK506 on protein synthesis and on regulatory initiation and elongation factors in rat pancreatic acini in vitro. CCK acutely increased protein synthesis in acini from normal rats with a maximum increase at 100 pM CCK to 170 ± 11 % of control. The immunosupressant FK506 dose-dependently inhibited CCK-stimulated protein synthesis over the same concentration range that blocked calcineurin activity as assessed by dephosphorylation of the calcineurin substrate CRHSP-24. Another immunosupressant, cyclosporine A inhibited protein synthesis but its effects appeared more complex. FK506 also inhibited protein synthesis stimulated by bombesin and carbachol. FK506 did not significantly affect the activity of the initiation factor-2B, or the phosphorylation of the initiation factor-2
, ribosomal protein protein S6 or the mRNA cap binding protein eIF4E. Instead, blockade of calcineurin with FK506 reduced the phosphorylation of the eIF4E binding protein, reduced the formation of the eIF4F complex and increased the phosphorylation of eEF2. From these results we conclude that calcineurin activity is required for protein synthesis, and this action may be related to an effect on the formation of the mRNA cap binding complex and the elongation processes.
This article has been cited by other articles:
![]() |
A. U. Shah, A. Sarwar, A. I. Orabi, S. Gautam, W. M. Grant, A. J. Park, A. U. Shah, J. Liu, P. K. Mistry, D. Jain, et al. Protease activation during in vivo pancreatitis is dependent on calcineurin activation Am J Physiol Gastrointest Liver Physiol, November 1, 2009; 297(5): G967 - G973. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Crozier, M. D. Sans, C. H. Lang, L. G. D'Alecy, S. A. Ernst, and J. A. Williams CCK-induced pancreatic growth is not limited by mitogenic capacity in mice Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1148 - G1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Gurda, L. Guo, S.-H. Lee, J. D. Molkentin, and J. A. Williams Cholecystokinin Activates Pancreatic Calcineurin-NFAT Signaling In Vitro and In Vivo Mol. Biol. Cell, January 1, 2008; 19(1): 198 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Z. Husain, W. M. Grant, F. S. Gorelick, M. H. Nathanson, and A. U. Shah Caerulein-induced intracellular pancreatic zymogen activation is dependent on calcineurin Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1594 - G1599. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |